title: Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association?
authors.affiliation: Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain. Electronic address: adrian.alegresanchez@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Alegre-Sánchez
authors.affiliation: Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain.
authors.forename: D
authors.initials: D
authors.lastname: de Perosanz-Lobo
authors.affiliation: Pathology Sevice, Ramon y Cajal Hospital, Madrid, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Pinilla-Pagnon
authors.affiliation: Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Muñoz-Zato
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000209:etiology*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib